Size View COA 20mg View COA 30mg View COA 40mg Research reference Overview Retatrutide (LY-3437943) is an investigational triple-receptor agonist that combines activity at the GLP-1, GIP and glucagon receptors in a single 39-residue peptide backbone
Reward System Modulation : According to emerging neuroscience research, GLP-1 medications may affect dopamine signaling in the brain's mesolimbic reward pathways, potentially reducing reward-seeking behavior related to highly palatable foods and decreasing emotional eating patterns
For patients who are not Amazon One Medical primary care members, the company is also offering on-demand, 24/7 telehealth prescription renewals for existing GLP-1 prescriptions for $29 via message consultation or $49 for video care
The prescriber recommendations for weight loss include "those with a BMI of 30 or above or a BMI of at least 27 and a coexisting condition such as diabetes, heart disease or sleep apnea may be considered for these medications," shares Melissa Mitri, M.S., RD, a nutrition writer and owner of Melissa Mitri Nutrition